Information for "Bittamucin"

Basic information

Display title	Bittamucin
Default sort key	Bittamucin
Page length (in bytes)	836
Namespace ID	0
Page ID	14664
Page content language	en - English
Page content model	wikitext
Indexing by robots	Allowed
Number of redirects to this page	0
Counted as a content page	Yes
Number of subpages of this page	0 (0 redirects; 0 non-redirects)

Edit	Allow all users (infinite)
Move	Allow all users (infinite)

Page creator	Joe Beaudoin Jr. (talk \| contribs)
Date of page creation	05:43, 13 February 2007
Latest editor	Joe Beaudoin Jr. (talk \| contribs)
Date of latest edit	16:39, 8 February 2025
Total number of edits	9
Recent number of edits (within past 90 days)	1
Recent number of distinct authors	1

Transcluded templates (12)	Templates used on this page: Template:0 (view source) (protected) Template:Callsign (view source) (protected) Template:Clear (view source) (protected) Template:Dis (view source) Template:Diswitch (view source) (protected) Template:Drugs (view source) Template:Navbar (view source) Template:Navigation box end (view source) Template:Navigation box start (view source) Template:RDM (view source) (protected) Template:TRS (view source) (protected) Template:Void (view source)

Description	Content
Article description: (`description`) This attribute controls the content of the `description` and `og:description` elements.	Bittamucin is a drug used to cure and as an inoculant against Mellorak infection. Bittamucin has a high success rate against the infection if administered within 48 hours immediately after the onset of symptoms, in conjunction with a day's bedrest. As supplies of the drug were relatively low, bittamucin...

Information from Extension:WikiSEO